30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dolan Matthew Vincent

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dolan Matthew Vincent's trades of DexCom Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-29
US DexCom Inc (DXCM)
PlS Planned sale
80,564 -29.0%
15.92
US$3,858,835 		80,564 -29.0% 15.92 US$3,858,835
2024-05-16 2024-05-15
US DexCom Inc (DXCM)
PlS Planned sale
90,358 +39.7%
48.06
US$497,895 		90,358 +39.7% 48.06 US$497,895
2024-05-15 2024-05-15
US DexCom Inc (DXCM)
PrS Proposed sale
67,122
128.47
US$2,755,998 		67,122 128.47 US$2,755,998
2024-04-16 2024-04-15
US DexCom Inc (DXCM)
PlS Planned sale
1,990 -4.5%
137.81
US$274,242 		1,990 -4.5% 137.81 US$274,242
2024-04-15 2024-04-15
US DexCom Inc (DXCM)
PrS Proposed sale
1,990
137.81
US$274,242 		1,990 137.81 US$274,242
2024-03-19 2024-03-15
US DexCom Inc (DXCM)
PlS Planned sale
1,003 -2.2%
131.39
US$131,785 		1,003 -2.2% 131.39 US$131,785
2024-03-19 2024-03-15
US DexCom Inc (DXCM)
PlS Planned sale
1,314 -2.8%
130.77
US$171,832 		1,314 -2.8% 130.77 US$171,832
2024-03-19 2024-03-15
US DexCom Inc (DXCM)
PlS Planned sale
1,886 -3.9%
129.18
US$243,641 		1,886 -3.9% 129.18 US$243,641
2024-03-15 2024-03-15
US DexCom Inc (DXCM)
PrS Proposed sale
4,203
130.21
US$547,259 		4,203 130.21 US$547,259
2024-03-14 2024-03-12
US DexCom Inc (DXCM)
S Sale
6,710 -12.1%
134.41
US$901,896 		6,710 -12.1% 134.41 US$901,896
2023-09-01 2023-09-01
US DexCom Inc (DXCM)
PlS Planned sale
56 -0.2%
102.32
US$5,730 		56 -0.2% 102.32 US$5,730
2023-03-17 2023-03-16
US DexCom Inc (DXCM)
PlS Planned sale
2,303 -6.4%
115.00
US$264,845 		2,303 -6.4% 115.00 US$264,845
2023-03-14 2023-03-13
US DexCom Inc (DXCM)
PlS Planned sale
6,229 -14.8%
106.27
US$661,956 		6,229 -14.8% 106.27 US$661,956
2023-03-06 2023-03-06
US DexCom Inc (DXCM)
PlS Planned sale
226 -0.8%
114.40
US$25,854 		226 -0.8% 114.40 US$25,854
2022-09-06 2022-09-01
US DexCom Inc (DXCM)
PlS Planned sale
5 -0.0%
81.63
US$408 		5 -0.0% 81.63 US$408
2022-03-17 2022-03-17
US DexCom Inc (DXCM)
PlS Planned sale
484 -6.8%
450.00
US$217,800 		484 -6.8% 450.00 US$217,800
2022-03-17 2022-03-16
US DexCom Inc (DXCM)
PlS Planned sale
686 -8.8%
425.00
US$291,550 		686 -8.8% 425.00 US$291,550
2022-03-17 2022-03-15
US DexCom Inc (DXCM)
PlS Planned sale
1,016 -11.5%
412.41
US$419,009 		1,016 -11.5% 412.41 US$419,009